Influx Healthtech Complete Financial Statements
INFLUX • Review detailed financials to uncover trends, confirm thesis & journal trades
5 Years of Data
2025 - 2021
Complete Financial Data Export
Export complete financial statements for Influx Healthtech (INFLUX).
Downloads include all available records across all periods.
For market performance, see the
INFLUX stock price today
.
Profitability Ratios
Net Profit Margin
12.38%
2025 data
EBITDA Margin
20.00%
2025 data
Operating Margin
20.00%
2025 data
Return on Assets
18.57%
2025 data
Return on Equity
36.11%
2025 data
Balance Sheet Ratios
Debt to Equity
1.94
2025 data
Equity Ratio
51.43%
2025 data
Asset Turnover
1.50
2025 data
Year-over-Year Growth Analysis
Comparing March 2025 vs Period
Revenue Growth
-100.0%
Year-over-Year
Net Profit Growth
-100.0%
Year-over-Year
EBITDA Growth
-100.0%
Year-over-Year
Expense Growth
-100.0%
Year-over-Year
Assets Growth
+70.7%
Year-over-Year
Equity Growth
+56.5%
Year-over-Year
Liabilities Growth
+70.7%
Year-over-Year
Operating Cash Flow Growth
-22.2%
Year-over-Year
Investing Cash Flow Growth
-12.5%
Year-over-Year
Financing Cash Flow Growth
+100.0%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 105 | 100 | 76 | 59 | 0 |
| Expenses | 0 | 84 | 83 | 65 | 53 | 0 |
| EBITDA | 0 | 21 | 17 | 11 | 6 | 0 |
| Operating Profit Margin % | 0.00% | 20.00% | 17.00% | 14.00% | 11.00% | 0.00% |
| Depreciation | 0 | 3 | 2 | 1 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 18 | 15 | 10 | 6 | 0 |
| Tax | 0 | 5 | 4 | 3 | 2 | 0 |
| Net Profit | 0 | 13 | 11 | 7 | 5 | 0 |
| Earnings Per Share (₹) | 0.00 | 7.36 | 6.13 | 3.96 | 1801.90 | -1.75 |
Related Pages for Influx Healthtech
Additional stock information and data for INFLUX
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| ASSETS | |||||
| Total Assets | 70 | 41 | 28 | 18 | 0 |
| Current Assets | 49 | 26 | 20 | 14 | 0 |
| Fixed Assets | 19 | 14 | 6 | 3 | 0 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 52 | 27 | 22 | 15 | 0 |
| LIABILITIES | |||||
| Total Liabilities | 70 | 41 | 28 | 18 | 0 |
| Current Liabilities | 0 | 0 | 0 | 1 | 0 |
| Non-Current Liabilities | |||||
| SHAREHOLDERS' EQUITY | |||||
| Total Equity | 36 | 23 | 12 | 5 | 0 |
| Share Capital | 18 | 0 | 0 | 0 | 0 |
| Reserves & Surplus | 18 | 23 | 12 | 5 | 0 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 |
|---|---|---|---|---|---|
| Operating Activities | 7 | 9 | 7 | 4 | 0 |
| Investing Activities | -9 | -8 | -5 | -3 | 0 |
| Financing Activities | 0 | -1 | 0 | 1 | 0 |
| Net Cash Flow | -2 | 0 | 2 | 1 | 0 |